Takeda Pharmaceutical Co. said Thursday it will supply 50 million doses of a coronavirus vaccine developed by U.S. drugmaker Moderna Inc. in Japan from the first half of next year.

The Japanese drugmaker said it will provide the vaccine based on a three-way agreement with Moderna and the Ministry of Health, Labor and Welfare once the vaccine has been approved.

==Kyodo

© Kyodo News International, Inc., source Newswire